Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istaroxime in Cardiogenic Shock Due to Acute Heart Failure
NCT07583446Phase 3Recruiting
- Sponsor
- Seismic Therapeutic
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of istaroxime in cardiogenic shock, Acute Heart Failure (AHF), sponsored by Seismic Therapeutic. Started Sep 2026; status: recruiting.
02
Drugs
istaroxime
03
Conditions
cardiogenic shockAcute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT07583446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07583446.